These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Epidemiological Profile and Clinicopathological, Therapeutic, and Prognostic Characteristics of Nasopharyngeal Carcinoma in Northern Morocco. Reffai A; Mesmoudi M; Derkaoui T; Ghailani Nourouti N; Barakat A; Sellal N; Mallick P; Bennani Mechita M Cancer Control; 2021; 28():10732748211050587. PubMed ID: 34664512 [TBL] [Abstract][Full Text] [Related]
5. Predictive epidemiological and clinical factors of nasopharyngeal carcinoma diagnosis: Adult versus pediatric population. Hasnaoui M; Lahmar R; Ben Mabrouk A; Masmoudi M; Mighri K; Driss N Int J Pediatr Otorhinolaryngol; 2020 Oct; 137():110203. PubMed ID: 32658801 [TBL] [Abstract][Full Text] [Related]
6. A Comprehensive Analysis of Treatment Management and Survival Outcomes in Nasopharyngeal Carcinoma. Goshtasbi K; Lehrich BM; Birkenbeuel JL; Abiri A; Harris JP; Kuan EC Otolaryngol Head Neck Surg; 2021 Jul; 165(1):93-103. PubMed ID: 33231508 [TBL] [Abstract][Full Text] [Related]
7. Nasopharyngeal carcinoma in Indonesia: epidemiology, incidence, signs, and symptoms at presentation. Adham M; Kurniawan AN; Muhtadi AI; Roezin A; Hermani B; Gondhowiardjo S; Tan IB; Middeldorp JM Chin J Cancer; 2012 Apr; 31(4):185-96. PubMed ID: 22313595 [TBL] [Abstract][Full Text] [Related]
8. Circulation EBV Mir-Bart-7 Relating to Clinical Manifestation in Nasopharyngeal Carcinoma. Wardana T; Gunawan L; Herawati C; Oktriani R; Anwar S; Astuti I; Aryandono T; Mubarika S Asian Pac J Cancer Prev; 2020 Sep; 21(9):2777-2782. PubMed ID: 32986380 [TBL] [Abstract][Full Text] [Related]
9. Incidence and Demographics of Nasopharyngeal Carcinoma in Cheung Chau Island of Hong Kong-A Distinct Geographical Area With Minimal Residential Mobility and Restricted Public Healthcare Referral Network. Chan SK; Chau SC; Chan SY; Tong CC; Lam KO; Lai-Wan Kwong D; Leung TW; Luk MY; Lee AW; Choi HC; Lee VH Cancer Control; 2021; 28():10732748211047117. PubMed ID: 34565216 [TBL] [Abstract][Full Text] [Related]
10. Lymph Node Status and Outcomes for Nasopharyngeal Carcinoma According to Histological Subtypes: A SEER Population-Based Retrospective Analysis. Guo R; Wu H; Wang J; Lian CL; He ZY; Zhang WW; Chen YX; Wu SG Adv Ther; 2019 Nov; 36(11):3123-3133. PubMed ID: 31559602 [TBL] [Abstract][Full Text] [Related]
11. Histopathological patterns of nasopharyngeal carcinoma in Sudan. Abuidris DO; Elgaili EM; Elhaj AH; Elmustafa OM Saudi Med J; 2008 Jul; 29(7):962-5. PubMed ID: 18626521 [TBL] [Abstract][Full Text] [Related]
12. Expression of potential therapeutic target SSTR2a in primary and metastatic non-keratinizing nasopharyngeal carcinoma. Tao L; Chen Y; Shi X; Yu G; Yin W; Huang Y Virchows Arch; 2020 Oct; 477(4):573-579. PubMed ID: 32328798 [TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus and Epstein-Barr virus in nasopharyngeal carcinoma in a non-endemic eastern european population. Svajdler M; Kaspirkova J; Mezencev R; Laco J; Torday T; Dubinsky P; Straka L; Ondic O; Michal M; Skalova A Neoplasma; 2016; 63(1):107-14. PubMed ID: 26639240 [TBL] [Abstract][Full Text] [Related]
14. Epidemiology of nasopharyngeal carcinoma in the United States: improved survival of Chinese patients within the keratinizing squamous cell carcinoma histology. Ou SI; Zell JA; Ziogas A; Anton-Culver H Ann Oncol; 2007 Jan; 18(1):29-35. PubMed ID: 17060483 [TBL] [Abstract][Full Text] [Related]
15. Nasopharyngeal carcinoma in Ibadan, Nigeria: a clinicopathologic study. Ogun GO; Olusanya AA; Akinmoladun VI; Adeyemo AA; Ogunkeyede SA; Daniel A; Awosusi BL; Fatunla EO; Fasunla AJ; Onakoya PA; Adeosun AA; Nwaorgu OG Pan Afr Med J; 2020; 36():82. PubMed ID: 32774641 [TBL] [Abstract][Full Text] [Related]
16. A nation-wide epidemiological study on the risk of developing second malignancies in patients with different histological subtypes of nasopharyngeal carcinoma. Ooft ML; van Ipenburg J; Braunius WW; Stegeman I; Wegner I; de Bree R; Overbeek LI; Koljenović S; Willems SM Oral Oncol; 2016 May; 56():40-6. PubMed ID: 27086485 [TBL] [Abstract][Full Text] [Related]
17. Histological subtype remains a prognostic factor for survival in nasopharyngeal carcinoma patients. Pan XX; Liu YJ; Yang W; Chen YF; Tang WB; Li CR Laryngoscope; 2020 Mar; 130(3):E83-E88. PubMed ID: 31188486 [TBL] [Abstract][Full Text] [Related]
18. Prognostic factors of nasopharyngeal carcinoma patients in a tertiary referral hospital: a retrospective cohort study. Siti-Azrin AH; Norsa'adah B; Naing NN BMC Res Notes; 2017 Dec; 10(1):705. PubMed ID: 29212521 [TBL] [Abstract][Full Text] [Related]
19. Lower mortality from nasopharyngeal cancer in The Netherlands since 1970 with differential incidence trends in histopathology. Arnold M; Wildeman MA; Visser O; Karim-Kos HE; Middeldorp JM; Fles R; Bing Tan I; Coebergh JW Oral Oncol; 2013 Mar; 49(3):237-43. PubMed ID: 23089459 [TBL] [Abstract][Full Text] [Related]
20. [Trend of changes on incidence and pathological proportions of nasopharyngeal carcinoma in Zhongshan city, Guangdong province, during 1970 - 2007]. Wei KR; Xu Y; Zhang WJ; Liang ZH; Liu J Zhonghua Liu Xing Bing Xue Za Zhi; 2011 Nov; 32(11):1135-8. PubMed ID: 22336551 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]